Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting neurological disorders. Shows potential in the development of serotonin and dopamine modulators due to its structural affinity with central nervous system receptors. Also employed in the design of enzyme inhibitors, particularly for proteases involved in neurodegenerative diseases. Its sulfone and tetrahydroisoquinoline moieties enhance binding selectivity, making it valuable in medicinal chemistry for optimizing drug candidates.